was

described in 1972, its possible to antagonize the gastric acid-

stimulating activity of histamine. The development of selective H2-

receptor antagonists has led to more effective therapy for peptic

disease.

H2-receptor antagonist - burimamide

Click To Flip the Card

Comments:

Histamine some terms

navigate_before navigate_next